Chromatin/Epigenetics(染色质/表观遗传学)
Epigenetics
Epigenetics means above genetics. It determines how much and whether a gene is expressed without changing DNA sequences. Epigenetic regulations include, 1. DNA methylation: the addition of methyl group to DNA, converting cytosine to 5-methylcytosine, mostly at CpG sites; 2. Histone modifications: posttranslational modificationEpigeneticss of histone proteins including acetylation, methylation, ubiquitylation, phosphorylation and sumoylation; 3. miRNAs: non-coding microRNA downregulating gene expression; 4. Prions: infectious proteins viewed as epigenetic agents capable of inducing a phenotype without changing the genome.
Products for Chromatin/Epigenetics
- Bromodomain(47)
- Aurora Kinase(57)
- DNA Methyltransferase(32)
- HDAC(176)
- Histone Acetyltransferases(71)
- Histone Demethylases(99)
- Histone Methyltransferase(204)
- HIF(91)
- JAK(154)
- MBT Domains(1)
- PARP(104)
- Pim(27)
- Protein Ser/Thr Phosphatases(31)
- RNA Polymerase(6)
- Sirtuin(70)
- Sphingosine Kinase-2(1)
- Polycomb repressive complex(2)
- SUMOylation(3)
- PAD(21)
- Epigenetic Reader Domain(205)
- MicroRNA(20)
- Chromodomain(1)
- Citrullination(20)
- DNA/RNA Demethylation(2)
- DNA/RNA Methylation(8)
- Histone Deacetylation(42)
- Histones/Histone Peptides(62)
- PHD Domains(1)
- Tandem Tudor & Tudor-like Domains(1)
- PRMT(2)
- Readers(1)
- Cat.No. 产品名称 Information
- GC39146 HIF-1 inhibitor-1 An inhibitor of HIF-1 signaling
-
GC39081
Reticuline
番荔枝碱
Reticuline 分离自 Litsea cubeba,通过 JAK2/STAT3 和 NF-κB 信号通路显示抗炎作用。Reticuline 还可抑制 TNF-α 和 IL-6 的 mRNA 表达,并降低 JAK2 和 STAT3 的磷酸化水平。 -
GC38839
Pseudoprotodioscin
伪原薯蓣皂苷
A steroidal saponin with diverse biological activities -
GC38767
Deoxyshikonin
去氧紫草素
Deoxyshikonin 是从 Lithospermum erythrorhizon Sieb 中分离得到的,具有抗肿瘤活性。 -
GC38742
BRD-6929
JQ12
An HDAC1 and HDAC2 inhibitor - GC45927 DS-437 A dual inhibitor of PRMT5 and PRMT7
- GC45908 (R)-BAY-598 An inhibitor of SMYD2
- GC45906 MC1742 An inhibitor of class I and class IIb HDACs
-
GC45808
OUL35
NSC39047
An inhibitor of PARP10 -
GC45772
6(5H)-Phenanthridinone
6(5H)-菲啶酮
An inhibitor of PARP1 and 2 -
GC45763
Tolcapone-d4
托卡朋-D4,Ro 40-7592-d4
An internal standard for the quantification of tolcapone - GC45717 Chlamydocin An HDAC inhibitor
- GC45640 TP-238 (hydrochloride) A chemical probe for the bromodomains of CECR2 and BPTF
- GC45609 ZLD1039 An inhibitor of EZH2
- GC38709 KDOAM-25 citrate KDOAM-25 citrate 是有效,高选择性的 KDM5 抑制剂,对 KDM5A,KDM5B,KDM5C,KDM5D 的 IC50 分别为 71 nM,19 nM,69 nM,69 nM。KDOAM-25 citrate 可增加转录起始位点的整体 H3K4 甲基化,并损害多发性骨髓瘤 MM1S 细胞的增殖。
-
GC38519
Ilorasertib hydrochloride
ABT-348 hydrochloride
A multi-kinase inhibitor - GC38474 MS645 MS645 是一种 BET bromodomains (BrD) 抑制剂,对于 BRD4-BD1/BD2 的 Ki 值为 18.4 nM。MS645 在空间上限制 BRD4 BrDs 的二价抑制,从而导致实体肿瘤细胞中 BRD4 转录活性的持续抑制。
- GC38469 CBP/p300-IN-3 P300/CBP-IN-3, a p300/CBP 组蛋白乙酰转移酶 (histone acetyltransferase) 抑制剂,化合物 6,来源于专利 WO 2019049061 A1。
-
GC38412
Crotonoside
巴豆苷; Isoguanosine
A guanosine analog with diverse biological activities - GC38163 Tazemetostat hydrobromide Tazemetostat hydrobromide (EPZ-6438 hydrobromide) 是一种有效,选择性,口服的 EZH2 抑制剂。Tazemetostat hydrobromide 抑制含有 PRC2 复合体的野生型 EZH2 的活性, Ki 值为 2.5±0.5 nM。Tazemetostat hydrobromide 抑制 EZH2,在肽测定和核小体测定中 IC50 分别为 11 和 16 nM。Tazemetostat hydrobromide 抑制大鼠 EZH2,IC50 为 4 nM。Tazemetostat hydrobromide 还抑制 EZH1,IC50 为 392 nM。
-
GC38062
Gambogenic acid
新藤黄酸
Gambogenic Acid, identified from Gamboge, is an inhibitor of the FGFR signaling pathway in erlotinib-resistant non-small-cell lung cancer (NSCLC) and exhibits anti-tumor effects. Gambogenic acid acts is also an effective inhibitor of EZH2 that specifically and covalently binds to Cys668 within the EZH2-SET domain, and triggers EZH2 ubiquitination. - GC38049 GSK8573 GSK8573 是 GSK2801 的非活性对照化合物。GSK8573 与 BRD9 具有结合活性,Kd 值为 1.04 μM,并且对 BAZ2A/B 和其他溴结构域家族无抑制活性。
-
GC38044
Fraxinellone
梣酮
A liminoid degradant with diverse biological activities - GA20605 Ac-Lys-AMC Ac-Lys-AMC(己酰胺),也称为 MAL,是组蛋白去乙酰化酶 HDAC 的荧光底物。
- GA20481 Ac-Arg-Gly-Lys(Ac)-AMC Ac-Arg-Gly-Lys(Ac)-AMC 是 HDAC 的底物。
- GC45548 Photoswitchable PAD Inhibitor (technical grade) A photoactivated PAD inhibitor
-
GC45503
L-Moses (hydrochloride)
L-45
A PCAF bromodomain inhibitor -
GC45489
K-Biotin-W-Histone H2B (108-125) (trifluoroacetate salt)
Histone H2BK-Biotin (108-125), K(Biotin)-W-Histone H2B (108-125), K(Biotin)WKHAVSEGTKAVTKYTSSK
A biotinylated peptide fragment of histone H2B -
GC45485
Histone H4R3Me2s (1-21)-GGK-biotin (trifluoroacetate salt)
Ac-SG-R(me2s)-GKGGKGLGKGGAKRHRKV-GGK(Biotin), Arg(Me2s)3-Histone H4 (1-21)-GGK(Biotin), Histone H4 (1-21) (Arg3me2s)
A biotinylated peptide fragment of histone H4 -
GC45484
Histone H3K9Me3 (3-17) (human, mouse, rat, porcine, bovine) (trifluoroacetate salt)
H-Thr-Lys-Gln-Thr-Ala-Arg-Lys(Me3)-Ser-Thr-Gly-Gly-Lys-Ala-Pro-Arg-OH, H3K9me3, Histone H3 (3-17) (Lys9me3), Lys(Me3)9-Histone H3 (3-17), TKQTAR-K(Me3)-STGGKAPR
A peptide fragment of histone H3 -
GC45483
Histone H3K9Me2 (3-17) (human, mouse, rat, porcine, bovine) (trifluoroacetate salt)
Histone H3 (3-17) (Lys9me2), H-Thr-Lys-Gln-Thr-Ala-Arg-Lys(Me2)-Ser-Thr-Gly-Gly-Lys-Ala-Pro-Arg-OH, Lys(Me2)9-Histone H3 (3-17), TKQTAR-K(Me2)-STGGKAPR
A peptide fragment of histone H3 -
GC45482
Histone H3K9Me1 (3-17) (human, mouse, rat, porcine, bovine) (trifluoroacetate salt)
Histone H3 (3-17) (Lys9me1), Lys(Me1)9-Histone H3 (3-17), TKQTAR-K(Me1)-STGGKAPR
A peptide fragment of histone H3 -
GC45481
Histone H3K79Me1 (69-89) amide (human, mouse, rat, bovine) (trifluoroacetate salt)
Histone H3 (69-89) (Lys79me1) amide, Lys(Me1)79-Histone H3 (69-89) amide, RLVREIAQDF-K(Me1)-TDLRFQSSAV-NH2
A peptide fragment of histone H3 -
GC45480
Histone H3K4Me3 (1-25) amide (human mouse, rat, porcine, bovine) (trifluoroacetate salt)
ART-K(Me3)-QTARKSTGGKAPRKQLATKAA-NH2, Histone H3 (1-25) (Lys4me3), H3K4me3, Lys(Me3)4-Histone H3 (1-25) amide
A peptide fragment of histone H3
-
GC45479
Histone H3K36Me3 (31-41) (trifluoroacetate salt)
Histone H3 (31-41) (Lys36me3), Lys(Me3)36-Histone H3 (31-41), STGGV-K(Me3)-KPHRY
A peptide fragment of histone H3 -
GC45478
Histone H3K36Me3 (26-46)-K-biotin (trifluoroacetate salt)
Histone H3 (26-46) (Lys36me3), Lys(Me3)36-Histone H3 (26-46)-K(Biotin), RKAAPATGGV-K(Me3)-KPHRYRPGTV-K(biotin)
A peptide fragment of histone H3 -
GC45477
Histone H3K14Ac/K18Ac/K23Ac/K27Ac (1-30)-GGK-biotin (trifluoroacetate salt)
ARTKQTARKSTGG-K(Ac)-APR-K(Ac)-QLAT-K(Ac)-AAR-K(Ac)-SAPGG-K(biotin), Histone H3 (1-30) (Lys14ac/Lys18ac/Lys23ac/Lys27ac), Lys(Ac)14/18/23/27-Histone H3 (1-30)-GGK(biotin)
A biotinylated fragment of histone H3 -
GC45476
Histone H3K14Ac/H3K23Ac (1-24)-GGK-biotin (trifluoroacetate salt)
ARTKQTARKSTGG-K(Ac)-APRKQLAT-K(Ac)-AGG-K(Biotin), Histone H3 (1-24) (Lys14ac/Lys23ac), Lys(Ac)14/23-Histone H3 (1-24)-GGK(Biotin)
A biotinylated peptide fragment of histone H3 -
GC45475
Histone H3 (1-35) (human, mouse, rat, bovine) (trifluoroacetate salt)
ARTKQTARKSTGGKAPRKQLATKAARKSAPATGGV
A peptide fragment of histone H3 -
GC45474
Histone H3 (1-25) amide (human, mouse, rat, porcine, bovine) (trifluoroacetate salt)
ARTKQTARKSTGGKAPRKQLATKAA-NH2
A peptide fragment of histone H3 - GC45402 CAY10729 (trifluoroacetate salt) (technical grade) A PAD1 inhibitor
- GC45389 BAY-6035 An inhibitor of SMYD3
- GC37971 ZM39923 A potent inhibitor of JAK3
- GC37966 ZINC13466751 ZINC13466751 是一种 HIF-1α/von Hippel-Lindau 相互作用的有效抑制剂,IC50 值为 2.0 ?M。
- GC37956 YUKA1 YUKA1 是一种有效、可透过细胞的赖氨酸脱甲基化酶 (KDM5A) 抑制剂,IC50 值为 2.66 μM,对 KDM5C 的作用较弱,IC50 值为 7.12 μM,对 KDM5B,KDM6A 或 KDM6B 无作用。YUKA1 可增加人细胞中 H3K4me3 的水平,具有抗肿瘤活性。
-
GC37889
VCE-004.8
VCE-?004.8
VCE-004.8 (VCE-004.8) 是一种具有口服活性的特异性 PPARγ;和 CB2 受体双重激动剂。 -
GC37881
Valemetostat tosylate
DS-3201 tosylate
Valemetostat tosylate (DS-3201 tosylate) 是一种首创的 EZH1/2 抑制剂,用于复发/难治性周围 T 细胞淋巴瘤的研究。 - GC37856 UNC0321 A highly potent inhibitor of G9a histone methyltransferase
- GC37847 Tyk2-IN-8 Ropsacitinib (PF-06826647, Tyk2-IN-8, compound 10) is a selective and orally administered inhibitor of tyrosine kinase 2 (TYK2) with IC50 of 17 nM for binding to TYK2 catalytically active JH1 domain. PF-06826647 (Tyk2-IN-8, compound 10) also inhibits JAK1 and JAK2 with IC50 of 383 nM and 74 nM, respectively. PF-06826647 (Tyk2-IN-8, compound 10) is used in the treatment of psoriasis (PSO).
- GC37846 Tyk2-IN-7 Tyk2-IN-7 (Compound 48) 是 TYK2 JH2 抑制剂,与 TYK2 JH2 结构域结合,IC50 和 Ki.app 分别为 0.00053 μM 和 0.00007 μM。Tyk2-IN-7 (Compound 48) 是常规 TYK2 正构抑制剂的高选择性替代,抑制 TYK2/JAK1/JAK2 激酶结构域。Tyk2-IN-7 (Compound 48) 抑制小鼠 IL-12 诱导的 IFNγ 药效学模型中以及抑制在 IL-23 和 IL-12 依赖性小鼠结肠炎模型中的功效。